AI assistant
Sending…
Predictive Oncology Inc. — Director's Dealing 2012
Aug 14, 2012
35106_dirs_2012-08-14_c775f6c6-652d-472a-a0c4-e6ef0207b5a6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BioDrain Medical, Inc. (BIOR)
CIK: 0001446159
Period of Report: 2012-08-13
Reporting Person: MYERS ROBERT L (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-08-13 | Stock Options (right to buy) | $0.08 | A | 1000000 | Acquired | 2022-08-13 | Common Stock (1000000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 0 | Direct |
Footnotes
F1: 700,000 shares vest immediately; 300,000 shares vest on 2/13/2014.
More from Predictive Oncology Inc.
Capital/Financing Update
2026
Jun 9
Regulatory Filings
2026
Jun 9
Earnings Release
2026
May 15
Capital/Financing Update
2026
May 15
Capital/Financing Update
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 22
Board/Management Information
2026
Apr 16
Board/Management Information
2026
Apr 1